Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BMS-5

Inhibitor of LIMK1 and LIMK2
 
ENZ-CHM178-0001 1 mg 51.00 USD
 
ENZ-CHM178-0005 5 mg 117.00 USD
Do you need bulk/larger quantities?
 
BMS-5 is a potent inhibitor of the LIM kinase. It has IC50 values of 7nM and 8 nM for LIMK1 and LIMK2 respectively. LIMK1/2 activity was measured via TCA precipitation assay using a biotinylated ADF (actin depolymization factor) as the protein substrate and the kinase domains of LlMKl and LIMK2 as the enzyme sources in the presence of 1 μM ATP.

Product Specification

Alternative Name:LIMKi 3, N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methylpropanamide
 
Formula:C17H14Cl2F2N4OS
 
MW:431.3
 
CAS:1338247-35-0
 
Purity:≥98% (HPLC)
 
Identity:Determined by EM-MS, NMR
 
Appearance:White powder.
 
Solubility:Soluble in DMSO (15mM).
 
Shipping:Ambient
 
Short Term Storage:+4°C
 
Long Term Storage:-20°C
 
Scientific Background:Kinases, such as LIM kinase 1 (LMK1) and LIM kinase 2 (LMK2), have been identified as participating in signal pathways affecting actin dynamics by deactivating cofilin. Over expression of LIMKl has been found in invasive breast and prostate cancer cell lines and suppression of LIMK 2 expression has been found to limit migration of human fibrosarcoma cells. Thus, the inhibition of LIMKl and/or LIMK2 enzymes have been suggested as targets for treating cancer, including reduction or prevention of metastasis.
 
ENZ-CHM178 structure
Please mouse over
ENZ-CHM178 structure

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
LIMK
By biological activity:
LIMK Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,